Close
Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Give the Gift of Market Intelligence - StreetInsider Premium
Home
Menu
Join Free
SI Premium
Ratings Insider
M&A Insider
EPS Insider
Dividend Insider
IPO Insider
Hedge Fund Insider
Premium Newsletters
Join Free
SI Premium
Full Feed View
Headline View
Upgrade to SI Premium
Ratings Insider
Upgrade News
Downgrade News
New Coverage News
More...
M&A Insider
Merger News
More...
EPS Insider
Earnings News
More...
Dividend Insider
Dividend News
More...
IPO Insider
IPO News
More...
Hedge Fund Insider
Hedge Funds News
More...
Premium Newsletters
QUICK LINKS :
Upcoming Dividends
EPS Movers
Top Upgrades
Buffett's Stocks
FREE SI Newsletters
Google
Follow @Street_Insider
Premium Content
News Feeds
Full Feed $
Today's Headlines
Custom Headlines
My Portfolio Headlines
Entities
Company News
Corporate News
Hot Corp. News $
Litigation
Management Changes
Hot Mgmt Changes $
Retail Sales
Dividends/Sh. Returns
Dividends $
Hot Dividends $
Special Dividends $
Stock Buybacks $
Hot Buybacks $
Stock Splits $
EPS
Conference Calls
Earnings $
Hot Earnings $
Guidance $
Hot Guidance $
ETFs
ETFs
FDA
FDA $
Hot FDA News $
Insiders/Hedge Funds
13Ds $
13Fs $
13Gs $
Hedge Funds $
Hot Hedge Fund News $
Insider Trades $
Hot Insider Trades $
M&A
Mergers and Acquisitions $
Hot M&A $
Private Equity
Rumors $
Macro
Commodities $
Economic Data
Fed
Market Check
Market Movers
Hot List $
Insiders' Blog
Momentum Movers $
Options $
Special Reports
Trading Halts $
Trader Talk $
Offerings
Equity Offerings
IPOs $
Hot IPOs $
Other
Reuters
Contributors
General News
Life Enjoyed
Rating Changes
Analyst Comments $
Hot Comments $
Credit Ratings
Downgrades $
Hot Downgrades $
New Coverage $
Hot New Coverage $
Upgrades $
Hot Upgrades $
Unfiltered Feeds
Press Releases
SI Newswire
SEC Filings
Top News
Pep Boys-manny Moe & Jack (PBY)
Testing article update a longer title perhaps
Apple, Inc. (AAPL)
Send to a Friend
Font Size:
Increase
Decrease
Earnings
Earnings News
Login to help us fill in information about this entity.
Intellect Neurosciences Files Appeal in Europe in Response to Opposition Proceedings Instituted by Elan Pharmaceuticals and Wyeth/Pfizer
Dec 15, 2011 09:35AM
Intellect Neurosciences, Inc. to Present at OneMedForum
Dec 14, 2011 09:35AM
Intellect Neurosciences Obtains Two New Patents in Japan for Its Alzheimer's Immunotherapy Programs
Nov 8, 2011 09:35AM
Intellect Neurosciences Responds to Official Action by United States Patent and Trademark Office in Relation to its ANTISENILIN® Alzheimer's Patent Application
Nov 3, 2011 09:35AM
ViroPharma Incorporated Reports Third Quarter 2011 Financial Results
Oct 27, 2011 07:05AM
Oct 26, 2011 09:35AM
Intellect Neurosciences Announces Its New CONJUMAB-A Platform Technology for Novel Treatments of Alzheimer's Disease and Other Proteinopathies
